Who is eligible for the Mounjaro?

Mounjaro (tirzepatide) is a once-weekly injection originally approved to treat type 2 diabetes, but it’s also making headlines for its dramatic weight loss results. If you’re considering Mounjaro for weight management or metabolic health, eligibility depends on your medical history, body weight, and insurance plan.

Here’s a breakdown of who qualifies and how to get started.

1. FDA-approved use: Type 2 diabetes

As of now, Mounjaro is officially approved by the FDA to treat type 2 diabetes. To qualify for this use, you must:

• Have a diagnosis of type 2 diabetes mellitus
• Be 18 years or older
• Not have type 1 diabetes or diabetic ketoacidosis
• Be under a provider’s care for managing blood sugar levels

Mounjaro improves insulin sensitivity, lowers A1C, and reduces appetite, making it a strong option for both blood sugar control and weight loss in diabetics.

2. Off-label use: Weight loss

While Mounjaro is not yet FDA-approved solely for weight loss, many doctors prescribe it off-label due to its powerful GLP-1/GIP activity. You may be eligible if:

• Your BMI is 30 or higher (obese), OR
• Your BMI is 27 or higher with a weight-related health condition like:
  • High blood pressure
  • High cholesterol
  • Prediabetes or insulin resistance
  • PCOS
  • Sleep apnea

Many patients without diabetes use Mounjaro successfully for chronic weight management, under a provider’s supervision.

3. What about Zepbound?

In late 2023, Zepbound was FDA-approved as the weight loss version of Mounjaro, using the exact same active ingredient (tirzepatide). If your insurance won’t cover Mounjaro for weight loss, your provider may switch you to Zepbound, which is specifically approved for:

• Adults with BMI ≥30, or
• BMI ≥27 plus a weight-related medical condition

Zepbound may be easier to access for weight loss if you don’t have diabetes.

4. Insurance and affordability

To get Mounjaro covered by insurance, you typically need to:

• Have a documented diagnosis of type 2 diabetes
• Show elevated A1C or difficulty managing blood sugar
• Submit a prior authorization through your provider

If using it for weight loss, many insurers will deny coverage for Mounjaro and instead recommend Zepbound. However:

• Savings cards are available from Eli Lilly
• Some urgent care or weight loss clinics offer discounted or compounded tirzepatide if insurance doesn’t help
• Manufacturer patient assistance programs may apply for low-income patients

5. Who should not use Mounjaro

You should avoid Mounjaro or speak to your doctor first if you:

• Have a history of medullary thyroid cancer or MEN 2 (multiple endocrine neoplasia)
• Are pregnant or breastfeeding
• Have a history of pancreatitis
• Are allergic to tirzepatide or its components

Always review your health history before starting any GLP-1/GIP medication.

When urgent care can help

Urgent care providers can help you:

• Determine if your BMI and health conditions meet eligibility
• Order bloodwork (A1C, cholesterol, thyroid, etc.)
• Start you on a tirzepatide plan (Mounjaro or Zepbound)
• Help navigate insurance paperwork or appeals
• Offer support with side effect management and follow-ups

This is an efficient and low-barrier way to begin your weight loss journey without waiting months for a specialist.

Final thought

You may qualify for Mounjaro if you have type 2 diabetes or if you meet weight-based criteria with related health risks. Whether prescribed as Mounjaro or Zepbound, tirzepatide is one of the most effective options for long-term weight loss, especially when guided by a medical provider.

If symptoms get worse or don’t improve, visit your local urgent care provider for professional evaluation.
Hey Did You Know We Have an IV Therapy Spa Inside? Check out our drip menu!